Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01626118 · ClinicalTrials.gov registry record · Phase 3
Study of Indomethacin Capsules to Treat Pain Following Bunionectomy
A Phase 3 study of Other Acute Postoperative Pain, sponsored by Iroko Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 373
- Enrollment target
- 4
- Study locations
NCT01626118 is a Phase 3 study of Other Acute Postoperative Pain that has completed, run by Iroko Pharmaceuticals. The registered enrollment target is 373 participants. The trial reports 4 study locations across 4 states.
The verdict
NCT01626118, a Phase 3 study of Other Acute Postoperative Pain, has completed, sponsored by Iroko Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 373 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to determine whether Indomethacin \[Test\] Capsules are safe and effective for the treatment of postoperative bunionectomy pain.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Indomethacin
Study Locations (4)
Arizona
- Premier Research Group Limited - Phoenix
Maryland
- Chesapeake Research Group, LLC - Pasadena
Texas
- Premier Research Group Limited - Austin
Utah
- Premier Research Group Limited - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 373 participants |
| Start Date | 2012-05 |
| Est. Completion | 2012-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01626118
The ClinicalTrials.gov registry entry for NCT01626118 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 373 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Iroko Pharmaceuticals, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Other Acute Postoperative Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01626118 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Arizona, Maryland, Texas.
Frequently Asked Questions
What is clinical trial NCT01626118 about?
NCT01626118 is a clinical study titled "Study of Indomethacin Capsules to Treat Pain Following Bunionectomy". The purpose of this study is to determine whether Indomethacin \[Test\] Capsules are safe and effective for the treatment of postoperative bunionectomy pain.
What is the current status of trial NCT01626118?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 373 participants. The study started on 2012-05. Estimated completion is 2012-08.
What conditions does trial NCT01626118 study?
This clinical trial studies the following conditions: Other Acute Postoperative Pain.
What interventions are being tested in trial NCT01626118?
The interventions under investigation include: Placebo (DRUG), Indomethacin (DRUG).
Who is sponsoring clinical trial NCT01626118?
This trial is sponsored by Iroko Pharmaceuticals, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01626118 being conducted?
This trial has 4 study locations across Arizona, Maryland, Texas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.